RIFAMPIN CAPSULES, USP

• Therapeutically equivalent to *Rifadin^® by Sanofi-Aventis

• AB rated - Orange Book Approved Drug Products

• Child Resistant Closure (CRC)

• Ready to label and dispense

• Convenient 30 day supply

     *Rifadin is a registered trademark of Sanofi-Aventis Corporation

(Note: Photographs are not to scale. Objects are not shown in actual size.)
300 mg Capsules
Front, Side and Back Views, 300 mg Capsules	Opaque orange capsules printed in white on one-half of the capsule in radial print "Rifampin 300" and on the other half in radial print "VP/018"
30 Capsules, 300 mg NDC 61748-018-30	60 Capsules, 300 mg NDC 61748-018-60
100 Capsules, 300 mg NDC 61748-018-01	VersaPack™ Unit Dose Maximum flexibility for Inpatient and Directly Observed Therapy (DOT) dispensing VersaPack™ Unit Dose 300 mg unit doxe 10 x 10 NDC 61748-018-11

150 mg Capsules
Front, Side and Back Views, 150 mg Capsules	Opaque orange capsules printed in white on one-half of the capsule in radial print "Rifampin 150" and on the other half in radial print "VP/015"
30 Capsules, 150 mg NDC 61748-015-30	VersaPack™ Unit Dose Maximum flexibility for Inpatient and Directly Observed Therapy (DOT) dispensing VersaPack™ Unit Dose 150 mg unit doxe 10 x 10 NDC 61748-015-11

Return to Top

For information or assistance,
call VersaPharm Customer Service:
1-800-548-0700
or E-mail: Info@VersaPharm.com

Package Insert

To Place Your Order

Page Return